IWP
GILD icon

Invenio Wealth Partners’s Gilead Sciences GILD Stock Holding History

Invenio Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Buy
3,294
+6
+0.2% +$791 0.15% 63
2026
Q1 		$458K Sell
3,288
-498
-13% -$69.7K 0.18% 57
2025
Q4 		$465K Sell
3,786
-15
-0.4% -$1.82K 0.17% 62
2025
Q3 		$422K Buy
3,801
+468
+14% +$53.2K 0.15% 67
2025
Q2 		$370K Buy
+3,333
New +$355K 0.15% 71

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invenio Wealth Partners's GILD Position: Q2 2026 in Review

Invenio Wealth Partners increased its Gilead Sciences (GILD) stake by 0.18% in Q2 2026, buying an estimated $791 and bringing the position to 3,294 shares worth $416K. The position accounts for 0.15% of the portfolio, ranked #63.

Invenio Wealth Partners first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $465K in Q4 2025. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Invenio Wealth Partners held 3,294 shares of Gilead Sciences worth $416K as of Q2 2026.
  • Invenio Wealth Partners bought 6 Gilead Sciences shares in Q2 2026, an estimated $791.
  • Gilead Sciences made up 0.15% of Invenio Wealth Partners's portfolio in Q2 2026, its #63 holding.
  • Invenio Wealth Partners first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Invenio Wealth Partners's Gilead Sciences position peaked at $465K in Q4 2025.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Invenio Wealth Partners's 13F filing for Q2 2026, filed 30 Jul 2026.